Pharmaceutical

Atantares raises $13.9m in pre-Series A funding to develop molecular chips

Atantares plans to use the $13.9m funding for research and development, service operation, and capacity expansion.

Aug 2, 2023 - 20:00
Atantares raises $13.9m in pre-Series A funding to develop molecular chips
Atantares plans to use the $13.9m funding for research and development, service operation, and capacity expansion.
Read the original article

Tags:

Previous Article

CS Pharmaceuticals snaps up AxeroVision to shore up ophthalmology portfolio

Next Article

FDA warns of reduced efficacy for oral birth control pill Tydemy

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

How competitive intelligence can give pharma companies an edge

How competitive intelligence can give pharma companies ...

Aug 18, 2023

Intercept winds down NASH programme after FDA pulls plug on Ocaliva

Intercept winds down NASH programme after FDA pulls plu...

Jun 23, 2023

STAT+: In early trial, drug appears to reduce harmful protein buildup in heart

STAT+: In early trial, drug appears to reduce harmful p...

May 21, 2023